Doctor profile · Federal record
Dr. Rachel Prytula, CRNP
Acute Care Nurse Practitioner · Dothan, AL
- NPI 1861827941
- MIPS 99.1 / 100 · 2023
- 13 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
287 Healthwest Dr
Dothan, AL 363032031
(334) 792-9500
fax (334) 793-1815
Credentials & registration
- NPI registered
- September 2013 — 13 yrs on file
- Profile last updated
- October 16, 2023
- Specialty taxonomy
- 363LA2100X — NUCC code
- State license (1)
- Alabama #1-110591
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861827941. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
406
Distinct HCPCS
3
Medicare allowed
$41,856
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 357 | 221 | $99 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 33 | 30 | $140 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 16 | 16 | $122 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 65. This provider delivers 6.2× the peer median.Open Payments
Industry payments received
All-time total
$3,034
Transactions
108
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $305.21 | |
| Incyte Corporation | 10 | $260.81 | |
| EAGLE PHARMACEUTICALS, INC. | 4 | $207.66 | |
| Regeneron Healthcare Solutions, Inc. | 8 | $197.88 | |
| PFIZER INC. | 14 | $180.68 | |
| Janssen Biotech, Inc. | 10 | $152.80 | |
| Genentech USA, Inc. | 8 | $151.59 | |
| Merck Sharp & Dohme LLC | 8 | $149.94 | |
| ABBVIE INC. | 6 | $146.72 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $98.61 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96.16 | |
| Lilly USA, LLC | 5 | $94.37 | |
| AstraZeneca Pharmaceuticals LP | 4 | $77.11 | |
| BeiGene USA, Inc. | 4 | $68.25 | |
| Ipsen Biopharmaceuticals, Inc | 3 | $66.95 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
547
Patients
76
Total drug cost
$3,522,228
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 84 | 21 | $1,644 |
| Imbruvica (Ibrutinib) | Brand | 71 | 0 | $1,202,506 |
| Ibrance (Palbociclib) | Brand | 51 | 0 | $810,691 |
| Xtandi (Enzalutamide) | Brand | 47 | 0 | $636,784 |
| Hydroxyurea | Generic | 46 | 0 | $1,557 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 44 | 0 | $581,945 |
| Ondansetron Hcl | Generic | 43 | 25 | $505 |
| Prochlorperazine Maleate | Generic | 26 | 18 | $396 |
| Aprepitant | Generic | 25 | 12 | $10,688 |
| Letrozole | Generic | 25 | 0 | $708 |
Frequently asked questions
What is Dr. Rachel Prytula's medical specialty?
Dr. Rachel Prytula practices Acute Care Nurse Practitioner in Dothan, AL.
Where does Dr. Rachel Prytula practice?
Dr. Rachel Prytula practices at 287 Healthwest Dr, Dothan, AL 363032031. Office phone: 3347929500.
What is Dr. Rachel Prytula's NPI?
Dr. Rachel Prytula's National Provider Identifier (NPI) is 1861827941, issued by NPPES.
What procedures does Dr. Rachel Prytula commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.